Professor David Price
Chair of Primary Care Respiratory Med
- About
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 12 of 18 Results 551 to 600 of 858
Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial
The Lancet. Respiratory medicine, vol. 2, no. 10, pp. 796-803Contributions to Journals: ArticlesIdentifying novel factors beyond prior hospitalisations, including biomarkers, associated with future asthma hospitalisation risk from routine UK primary care clinical records
Allergy, vol. 69, pp. 61Contributions to Journals: ArticlesManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns
International journal of chronic obstructive pulmonary disease , vol. 9, pp. 889-905Contributions to Journals: ArticlesIntegrated care pathways for airway diseases (AIRWAYS-ICPs)
European Respiratory Journal, vol. 44, no. 2, pp. 304-323Contributions to Journals: ArticlesDetection of airflow limitation using a handheld spirometer in a primary care setting
Respirology, vol. 19, no. 5, pp. 689-693Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/resp.12291
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/4077/1/resp12291.pdf
Current evidence and future research needs for FeNO measurement in respiratory diseases
Respiratory Medicine, vol. 108, no. 6, pp. 830-841Contributions to Journals: ArticlesFluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma
Expert Review of Respiratory Medicine, vol. 8, no. 3, pp. 275-291Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1586/17476348.2014.905914
Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients
Journal of Asthma and Allergy, vol. 7, pp. 31-51Contributions to Journals: ArticlesOpportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort
The Lancet. Respiratory medicine, vol. 2, no. 4, pp. 267-276Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S2213-2600(14)70008-6
Integrating evidence for managing asthma in patients who smoke
Allergy, Asthma & Immunology Research, vol. 6, no. 2, pp. 114-120Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.4168/aair.2014.6.2.114
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/3924/1/aair_6_114.pdf
Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis
The Journal of Allergy and Clinical Immunology: In Practice, vol. 2, no. 2, pp. 179-185Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.jaip.2013.09.019
Types, frequency and impact of asthma triggers on patients' lives: a quantitative study in five European countries
Journal of Asthma, vol. 51, no. 2, pp. 127-135Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3109/02770903.2013.846369
Complementing the randomized controlled trial evidence base. Evolution not revolution
Annals of the American Thoracic Society, vol. 11 , no. Suppl 2, pp. S92-98Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1513/AnnalsATS.201308-276RM
Quality standards for real-world research. Focus on observational database studies of comparative effectiveness
Annals of the American Thoracic Society, vol. 11 , no. Suppl 2, pp. S99-104Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1513/AnnalsATS.201309-300RM
The arch conference declaration. Helping to further the science of pragmatic research
Annals of the American Thoracic Society, vol. 11 , no. Suppl 2, pp. S83-84Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1513/AnnalsATS.201308-256RM
Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey
npj Primary Care Respiratory Medicine, vol. 24, 14009Contributions to Journals: ArticlesCost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study
npj Primary Care Respiratory Medicine, vol. 24, 14081Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/npjpcrm.2014.81
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/3807/1/npjpcrm201481.pdf
Interstitial lung disease: raising the index of suspicion in primary care
npj Primary Care Respiratory Medicine, vol. 24, 14054Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/npjpcrm.2014.54
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/3750/1/npjpcrm201454.pdf
Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?
npj Primary Care Respiratory Medicine, vol. 24, 14023Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/npjpcrm.2014.23
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/3805/1/npjpcrm201423.pdf
Systems Medicine Approaches for the Definition of Complex Phenotypes in Chronic Diseases and Ageing: From Concept to Implementation and Policies
Current Pharmaceutical Design, vol. 20, no. 38, pp. 5928-5944Contributions to Journals: ArticlesFeasibility and ethics
American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 11, pp. 1368-1369Contributions to Journals: Letters- [ONLINE] DOI: https://doi.org/10.1164/rccm.201307-1250LE
Prescription of inhalers in asthma and COPD: Towards a rational, rapid and effective approach
Respiratory Medicine, vol. 107, no. 12, pp. 1817-1821Contributions to Journals: Review articles- [ONLINE] DOI: https://doi.org/10.1016/j.rmed.2013.09.013
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/11264/1/1_s2.0_S0954611113003788_main.pdf
- [ONLINE] View publication in Scopus
Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients
Primary Care Respiratory Journal, vol. 22, no. 4, pp. 439-448Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.4104/pcrj.2013.00088
Integrating real-life studies in the global therapeutic research framework
The Lancet. Respiratory medicine, vol. 1, no. 10, pp. e29-e30Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S2213-2600(13)70199-1
Impact of night-time symptoms in COPD: a real-world study in five European countries
International journal of chronic obstructive pulmonary disease , vol. 8, pp. 595-603Contributions to Journals: ArticlesUsing fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care
Clinical and Translational Allergy, vol. 3, no. 1, pp. 37Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1186/2045-7022-3-37
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/3712/1/2045_7022_3_37.pdf
Challenges of COPD diagnosis
Expert Opinion on Medical Diagnostics, vol. 7, no. 6, pp. 543-556Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1517/17530059.2013.842552
Effectiveness of inhaler devices in adult asthma and COPD
European Medical Journal - Respiratory, vol. 1, pp. 64-71Contributions to Journals: ArticlesA New Therapy (MP29-02) Is Effective for the Long-Term Treatment of Chronic Rhinitis
Journal of Investigational Allergology and Clinical Immunology, vol. 23, no. 7, pp. 495-503Contributions to Journals: ArticlesAsthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone
Journal of Allergy and Clinical Immunology, vol. 132, no. 1, pp. 45-54.e10Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.jaci.2013.02.008
Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis
International Archives of Allergy and Immunology, vol. 161, no. 4, pp. 369-377Contributions to Journals: ArticlesReal-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma
Respiratory Medicine, vol. 107, no. 7, pp. 987-1000Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.rmed.2013.03.009
A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use
Applied Health Economics and Health Policy, vol. 11, no. 3, pp. 259-274Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s40258-013-0021-5
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/5735/1/COPD.pdf
InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients: the LIAISON study protocol
BMC Pulmonary Medicine, vol. 13, 18Contributions to Journals: ArticlesCharacteristics of patients preferring once-daily controller therapy for asthma and COPD: A retrospective cohort study
Primary Care Respiratory Journal, vol. 22, no. 2, pp. 161-168Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.4104/pcrj.2013.00017
A BOLD statement on how to case-find moderate/severe COPD
European Respiratory Journal, vol. 41, no. 3, pp. 503-504Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1183/09031936.00153512
Effect of montelukast for treatment of asthma in cigarette smokers
Journal of Allergy and Clinical Immunology, vol. 131, no. 3, pp. 763-771.e6Contributions to Journals: ArticlesGOLD COPD categories are not fit for purpose in primary care
The Lancet. Respiratory medicine, vol. 1, no. 1, pp. e17Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S2213-2600(13)70015-8
Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD
Primary Care Respiratory Journal, vol. 22, pp. 92-100Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.4104/pcrj.2012.00092
Efficacy versus effectiveness trials: informing guidelines for asthma management
Current Opinion in Allergy and Clinical Immunology, vol. 13, no. 1, pp. 50-57Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1097/ACI.0b013e32835ad059
Improving clinical reality in chronic obstructive pulmonary disease economic modelling: Development and validation of a micro-simulation approach
Pharmacoeconomics, vol. 31, pp. 151-161Contributions to Journals: ArticlesManagement of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety
Health Technology Assessment, vol. 17, no. 4Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3310/hta17040
What we should learn from the London Olympics
Current Opinion in Allergy and Clinical Immunology, vol. 13, no. 1, pp. 1-3Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1097/ACI.0b013e32835c1b73
Inhaler competence in asthma: common errors, barriers to use and recommended solutions
Respiratory Medicine, vol. 107, no. 1, pp. 37-46Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.rmed.2012.09.017
Effect of Inhaled Corticosteroid Therapy Step-Down and Dosing Regimen on Measures of Asthma Control
Journal of Allergy & Therapy, vol. 4, no. 1, 126Contributions to Journals: ArticlesThe BREATHE study: Breathing REtraining for Asthma - trial of home exercises. A protocol summary of a randomised controlled trial
Primary Care Respiratory Journal, vol. 22, no. 2, pp. PS1-PS7Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.4104/pcrj.2013.00047
Real-world perceptions of inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma
Respiratory Medicine, vol. 106, no. Suppl 1, pp. S4-S8Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S0954-6111(12)70004-5
The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary care
Thorax, vol. 67, no. 12, pp. 1052-1060Contributions to Journals: Articles- [ONLINE] http://www.ncbi.nlm.nih.gov/pubmed
- [ONLINE] DOI: https://doi.org/10.1136/thoraxjnl-2012-202093
Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis
Allergy and Asthma Proceedings, vol. 33, no. 6, pp. 450-458Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.2500/aap.2012.33.3626
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
Journal of Allergy and Clinical Immunology, vol. 130, no. 5, pp. 1049-1062Contributions to Journals: Articles